A new spin-off of Amsterdam UMC, location AMC, HaemoPulse, started in the first months of 2019. HaemoPulse will develop non-invasive optical technology for continuous real-time monitoring of blood hematocrit.
Being able to measure hematocrit in such a manner opens a wide range of clinical applications, such as tracking of fluid balance in critically ill patients in the ICU, or monitoring of fluid retention of dialysis patients between dialysis treatments. Current clinical techniques for such measurements are insufficiently accurate or require expensive, time-consuming, lab testing of invasively acquired blood samples.
HaemoPulse intends to provide the technology that provides doctors with critical information on fluid balance and blood hematocrit that they currently lack. The scientific founder, Dr. Alan Riordan, is an AMC researcher and the company is developing the technology with the biomedical optics research group of Prof. Ton van Leeuwen at AMC.
Amsterdam UMC and Quantib, leader in Medical Imaging AI solutions, announce their partnership to develop and validate AI software in a joint venture with University Medical Center Utrecht, named Quantib-U. As part of the deal, Amsterdam UMC will provide access to data and allocate one of its top AI Medical Imaging scientists to projects within […]News
Het project ‘De online Vriendschapscursus’ van Vrije Universiteit onderzoeker Tamara Bouwman is genomineerd voor de Medische Inspirator Prijs. Het project dat gericht is om eenzame ouderen uit hun sociale isolement te halen is een van de twee projecten die in de running is voor de hoofdprijs van € 100.000. Om de prijs te winnen moet […]News
On the 17th of October, 70 KTO colleagues from the different universities of the Netherlands came together to participate in the annual KTO Masterclass as part of CES Unveiled at the Beurs van Berlage, hosted by IXA. Gigi Wang kicked of the day with an energizing presentation. Gigi runs the MG-Team, which delivers global entrepreneurship […]News